Conversation with The Cancer Letter WHO’s Ilbawi: St. Jude partnership can resolve inequality, capacity issues in childhood cancer October 12, 2018Vol.44 No.38By Matthew Bin Han Ong
Conversation with The Cancer Letter St. Jude’s Downing: WHO effort can raise cure rates up to 60% for children with cancer October 12, 2018Vol.44 No.38By Matthew Bin Han Ong
St. Jude and the World Health Organization collaborate in first-ever global alliance to boost cancer cure rates in children October 12, 2018Vol.44 No.38By Matthew Bin Han Ong
Drugs & Targets FDA approves Kyprolis with dexamethasone for relapsed or refractory multiple myeloma October 05, 2018Vol.44 No.37
Drugs & Targets FDA authorizes first next-gen sequencing-based test in patients with ALL, MM October 05, 2018Vol.44 No.37
Drugs & Targets FDA approves Libtayo as first and only treatment for advanced CSCC October 05, 2018Vol.44 No.37
Clinical Roundup Aspirin lowers risk of ovarian and hepatocellular cancer October 05, 2018Vol.44 No.37
Clinical Roundup Genentech’s Entrectinib showed durable response of more than two years NSCLC October 05, 2018Vol.44 No.37
Trials & Tribulations How tumor-specific modulation frequencies were discovered October 05, 2018Vol.44 No.37By Boris C. Pasche
